$NRXP 4 SEC Filings

Filed On	Filing
17 Feb 2026	Form 4: Casper Joseph Michael, Chief Operating Officer Granted 100,000 Stock Option (right to buy)
10 Sep 2025	Form 4: Javitt Jonathan C, Director Granted 125,000 Stock Option (right to buy)
10 Sep 2025	Form 4: McBride Dennis, Director Granted 25,000 Stock Option (right to buy)
10 Sep 2025	Form 4: Hurvitz Chaim, Director Granted 25,000 Stock Option (right to buy)
10 Sep 2025	Form 4: Flynn Patrick John, Director Granted 50,000 Stock Option (right to buy)
11 Feb 2025	Form 4: Abrams Michael S, Chief Financial Officer Granted 50,000 Stock Option (right to buy)
18 Dec 2024	Form 4: Javitt Jonathan C, Director Bought 40,000 shares ($46.8K)
11 Sep 2023	Form 4: Gorovitz Aaron, Director Bought 35,000 shares ($11.2K)
11 Sep 2023	Form 4: Hurvitz Chaim, Director Bought 70,000 shares ($20.1K)
24 Aug 2023	Form 4: Javitt Jonathan C, Director Bought 100,000 shares ($33K)
23 Aug 2023	Form 4: Javitt Jonathan C, Director Bought 200,000 shares ($64.4K)
19 Dec 2022	Form 4: Willard Stephen H, Director Bought 50,000 shares ($58.5K)
19 Dec 2022	Form 4: Van Voorhees Seth, CHIEF FINANCIAL OFFICER Bought 30,000 shares ($33K)
09 Dec 2022	Form 4: Javitt Jonathan C, Director Sold 400,000 shares ($400K)
01 Dec 2022	Form 4: Javitt Daniel C., 10% owner Sold 13,730 shares ($20.7K) · Sold 8,441 shares ($12.7K)
29 Nov 2022	Form 4: Flynn Patrick John, Director Bought 11,750 shares ($14.7K)
28 Nov 2022	Form 4: Van Voorhees Seth, CHIEF FINANCIAL OFFICER Bought 16,337 shares ($18.2K)
22 Nov 2022	Form 4: Gorovitz Aaron, Director Granted 162,660 Employee Stock Option
22 Nov 2022	Form 4: Glied Sharon, Director Granted 162,660 Employee Stock Option
22 Nov 2022	Form 4: Flynn Patrick John, Director Granted 162,660 Employee Stock Option

Comments